Pemetrexed–bevacizumab effective maintenance therapy for NSCLC

Pemetrexed in combination with bevacizumab is superior to bevacizumab alone when given as continuation maintenance therapy in patients with advanced nonsquamous non-small-cell lung cancer, results of the AVAPERL trial show.

via Med Wire News